<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39376975</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>India's Potential as a Leader in Cancer Care Progress in the Future: A Synthetic Interdisciplinary Perspective.</ArticleTitle><Pagination><StartPage>e70892</StartPage><MedlinePgn>e70892</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70892</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.70892</ELocationID><Abstract><AbstractText>This paper comprehensively analyzes India's potential to become a leader in cancer care in the Global South, particularly in precision population cancer medicine (PPCM). Through an interdisciplinary lens, it examines the current landscape of cancer care in India, highlighting its strengths, weaknesses, opportunities, and threats in this domain. This review explores the concept of knowledge translation and its importance in bridging the gap between knowledge generation and implementation in medical sciences and applies this to the Indian healthcare scenario. The review then delves into India's technological prowess, exemplified by its digital health initiatives such as the CoWIN (winning over COVID-19) app and the Ayushman Bharat Digital Mission, which provide a strong foundation for leveraging advanced technologies in healthcare. The authors discuss India's pharmaceutical industry, often referred to as the "pharmacy of the world," emphasizing its crucial role in global drug manufacturing and distribution. It also examines the country's emerging genomic research landscape, including initiatives such as GenomeIndia and the Indian Cancer Genome Atlas Foundation, which are pivotal for advancing personalized medicine. A significant portion of the review is dedicated to analyzing India's clinical trial ecosystem. It traces the evolution of regulatory frameworks governing clinical research in the country and highlights recent reforms that have made India an increasingly attractive destination for global studies, the potential adoption of innovative trial designs and artificial intelligence (AI)-driven analyses. Crucially, the authors confront the formidable obstacles inherent in India's complex healthcare landscape, illuminating the unique challenges that must be overcome. The review acknowledges India's underrepresentation in global clinical trials despite its large population and significant cancer burden. The issue of financial toxicity in cancer care is discussed, underscoring the need for affordable treatment options. The study also points out the nascent state of India's genomic databases, which account for only a small percentage of global genetic data. Despite these challenges, the authors posit that by effectively leveraging its information technology (IT) infrastructure, robust pharmaceutical sector, and large, diverse population, India has the potential to develop unique, country-specific solutions for cancer care. The study suggests that by fostering genomic research, strategically reforming its clinical trial ecosystem, and harnessing its digital capabilities, India could transform its cancer care landscape and emerge as a model for other developing nations in the Global South. In essence, this paper provides a roadmap for India's journey towards becoming a leader in PPCM, offering valuable insights for policymakers, healthcare professionals, and researchers in the field of oncology and precision medicine. Indeed, by using PPCM as a "pilot project," India can learn to use its new strategies to improve non-cancer care disease prevention, early detection, and improved and more cost-effective management. This approach could revolutionize cancer care in India and serve as a model for other developing nations in the Global South. By leveraging the strategies and technologies developed for PPCM, India could significantly enhance its healthcare system, highlighting the importance and urgency of improving cancer care in the region.</AbstractText><CopyrightInformation>Copyright © 2024, Singh et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Anshul</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Radiotherapy and Oncology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velu</LastName><ForeName>Umesh</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Radiotherapy and Oncology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>Shirley</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Radiotherapy and Oncology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nittala</LastName><ForeName>Roselin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Radiation Oncology, University of Mississippi Medical Center, Jackson, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Johnny</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Radiation Oncology, University of Mississippi Medical Center, Jackson, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vijayakumar</LastName><ForeName>Srinivasan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Radiotherapy and Oncology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, IND.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radiotherapy and Oncology, Cancer Care Advisors and Consultants LLC, Ridgeland, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">big data</Keyword><Keyword MajorTopicYN="N">genomic medicine</Keyword><Keyword MajorTopicYN="N">india</Keyword><Keyword MajorTopicYN="N">precision medicine</Keyword><Keyword MajorTopicYN="N">precision population medicine</Keyword></KeywordList><CoiStatement>Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>10</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>10</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>4</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39376975</ArticleId><ArticleId IdType="pmc">PMC11457899</ArticleId><ArticleId IdType="doi">10.7759/cureus.70892</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Manns BJ. Clinical Epidemiology. Vol. 2249. New York (NY): Humana; 2021. Evidence-based decision making 5: knowledge translation and the knowledge to action cycle; pp. 467–482.</Citation><ArticleIdList><ArticleId IdType="pubmed">33871859</ArticleId></ArticleIdList></Reference><Reference><Citation>Data, information, evidence, and knowledge: a proposal for health informatics and data science. Dammann O. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435353/ Online J Public Health Inform. 2019;10:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6435353</ArticleId><ArticleId IdType="pubmed">30931086</ArticleId></ArticleIdList></Reference><Reference><Citation>Can we streamline the concepts of knowledge translation, dissemination and implementation for lay stakeholders? A perspective. Daraz L, Morshed KG. BMJ Open. 2023;13:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10040022</ArticleId><ArticleId IdType="pubmed">36958773</ArticleId></ArticleIdList></Reference><Reference><Citation>Lost in knowledge translation: time for a map? Graham ID, Logan J, Harrison MB, Straus SE, Tetroe J, Caswell W, Robinson N. J Contin Educ Health Prof. 2006;26:13–24.</Citation><ArticleIdList><ArticleId IdType="pubmed">16557505</ArticleId></ArticleIdList></Reference><Reference><Citation>From data to wisdom.  [
Jul;
2024 
];Ackoff RL.  http://faculty.ung.edu/kmelton/Documents/DataWisdom.pdf J Appl Syst Anal. 1999 16:3–9.</Citation></Reference><Reference><Citation>Interdisciplinary research as a complicated system. Dalton A, Wolff K, Bekker B. Int J Qual Methods. 2022;21</Citation></Reference><Reference><Citation>Learn about interdisciplinary research.  [
Jul;
2024 
]. 2024. https://new.nsf.gov/funding/learn/research-types/learn-about-interdisciplinary-research https://new.nsf.gov/funding/learn/research-types/learn-about-interdisciplinary-research</Citation></Reference><Reference><Citation>Bear A. The Integration of the Humanities and Arts With Sciences, Engineering, and Medicine in Higher Education: Branches From the Same Tree. Washington (DC): National Academies Press; 2018. What is integration?</Citation><ArticleIdList><ArticleId IdType="pubmed">29989765</ArticleId></ArticleIdList></Reference><Reference><Citation>Towards a theory of change to institutionalise integration experts and expertise.  [
Jul;
2024 
]. 2023. https://i2insights.org/2023/06/06/institutionalising-integration-expertise/ https://i2insights.org/2023/06/06/institutionalising-integration-expertise/</Citation></Reference><Reference><Citation>Integrate the integrators! A call for establishing academic careers for integration experts. Hoffmann S, Deutsch L, Klein JT, O'Rourke M. Humanit Soc Sci Commun. 2022;9:147.</Citation></Reference><Reference><Citation>Conceptualizing the (dis)unity of science. Grantham TA. Philos Sci. 2004;71:133–155.</Citation></Reference><Reference><Citation>The philosophy of interdisciplinarity: sustainability science and problem-feeding. Thorén H, Persson J. J Gen Philos Sci. 2013;44:337–355.</Citation></Reference><Reference><Citation>Multidisciplinary, interdisciplinary, and transdisciplinary collaboration: implications for vocational psychology. Collin A. Int J Educ Vocat Guidance. 2009;9:101–110.</Citation></Reference><Reference><Citation>Interdisciplinary approach - advantages, disadvantages, and the future benefits of interdisciplinary studies. Jones C. http://dc.cod.edu/essai/vol7/iss1/26 ESSAI. 2009;7:2.</Citation></Reference><Reference><Citation>Ten cheers for interdisciplinarity: the case for interdisciplinary knowledge and research. Nissani M. Soc Sci J. 1997;34:201–216.</Citation></Reference><Reference><Citation>The organization of interdisciplinary research: modes, drivers and barriers. Siedlok F, Hibbert P. Int J Manag Rev. 2014;16:194–210.</Citation></Reference><Reference><Citation>Winskel M., Ketsopoulou I., Churchouse T. UKERC interdisciplinary review: research report 2014.  [
Jul;
2024 
]. 2014. https://ukerc.ac.uk/publications/ukerc-interdisciplinary-review-synthesis-report/download https://ukerc.ac.uk/publications/ukerc-interdisciplinary-review-synthesis-report/download</Citation></Reference><Reference><Citation>Precision medicine in cancer prevention: exploring applications in Mississippi and beyond. Vijayakumar S, Roberts PR, Packianathan S. https://issuu.com/jmsmamanagingeditor/docs/jan_2017_final/6. J Miss State Med Assoc. 2017;58:4–7.</Citation><ArticleIdList><ArticleId IdType="pubmed">30398721</ArticleId></ArticleIdList></Reference><Reference><Citation>An overview of the use of precision population medicine in cancer care: first of a series. Yang J, Nittala MR, Velazquez AE, Buddala V, Vijayakumar S. Cureus. 2023;15:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10129036</ArticleId><ArticleId IdType="pubmed">37113463</ArticleId></ArticleIdList></Reference><Reference><Citation>Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Naghavi M, Ong KL, Aali A, et al. Lancet. 2024;403:2100–2132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11126520</ArticleId><ArticleId IdType="pubmed">38582094</ArticleId></ArticleIdList></Reference><Reference><Citation>India's vaccine production capacity is best asset world has today, says UN chief.  [
Jul;
2024 
]; https://www.hindustantimes.com/world-news/indias-vaccine-production-capacity-is-best-asset-world-has-today-says-un-chief-101611886527685.html Hindustan Times. 2021 7:7–2024.</Citation></Reference><Reference><Citation>Avhad P. The Indian pharmaceutical industry, the ‘pharmacy of the world’?  [
Jul;
2024 
]. 2020.  https://blogs.deloitte.co.uk/health/2020/03/the-indian-pharmaceutical-industry-the-pharmacy-of-the-world.html  https://blogs.deloitte.co.uk/health/2020/03/the-indian-pharmaceutical-industry-the-pharmacy-of-the-world.html</Citation></Reference><Reference><Citation>India: pharmacy to the world.  [
Jul;
2024 
];Srividhya Srividhya, Datt S, Sharma A. https://www.investindia.gov.in/siru/india-pharmacy-world World. 2020 7:0.</Citation></Reference><Reference><Citation>India marks one year of COVID vaccination.  [
Jul;
2024 
];https://www.who.int/india/news/feature-stories/detail/india-marks-one-year-of-covid-vaccination 2022 7:0.</Citation></Reference><Reference><Citation>India's fight against pandemic aided by successful coWIN app.  [
Jul;
2024 
];Pant M. https://www.undp.org/blog/indias-fight-against-pandemic-aided-successful-cowin-app 2022 9:0.</Citation></Reference><Reference><Citation>Strategy for COVID-19 vaccination in India: the country with the second highest population and number of cases. Kumar VM, Pandi-Perumal SR, Trakht I, Thyagarajan SP. NPJ Vaccines. 2021;6:60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8169891</ArticleId><ArticleId IdType="pubmed">33883557</ArticleId></ArticleIdList></Reference><Reference><Citation>Global strategy on digital health 2020-2025.  [
Jul;
2024 
]. 2021. https://www.who.int/publications/i/item/9789240020924 https://www.who.int/publications/i/item/9789240020924</Citation></Reference><Reference><Citation>Socioeconomic status and access to healthcare: interrelated drivers for healthy aging. McMaughan DJ, Oloruntoba O, Smith ML. Front Public Health. 2020;8:231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314918</ArticleId><ArticleId IdType="pubmed">32626678</ArticleId></ArticleIdList></Reference><Reference><Citation>Digital Bharat Nidhi. BharatNet project. BharatNet Project.  [
Jul;
2024 
]. 2024.  https://usof.gov.in/en/bharatnet-project  https://usof.gov.in/en/bharatnet-project</Citation></Reference><Reference><Citation>National digital summit report.  [
Jul;
2024 
]. 2023. https://www2.deloitte.com/content/dam/Deloitte/in/Documents/public-sector/in-ps-National-Digital-Summit-Report-noexp.pdf https://www2.deloitte.com/content/dam/Deloitte/in/Documents/public-sector/in-ps-National-Digital-Summit-Report-noexp.pdf</Citation></Reference><Reference><Citation>Accelerating digitisation in healthcare delivery.  [
Jul;
2024 
]. 2022. https://abdm.gov.in:8081/uploads/Accelerating_Digitisation_in_Healthcare_Delivery_v3_fad6fe700f.pdf https://abdm.gov.in:8081/uploads/Accelerating_Digitisation_in_Healthcare_Delivery_v3_fad6fe700f.pdf</Citation></Reference><Reference><Citation>Nishith Desai. Digital health in India.  [
Aug;
2024 
]. 2024. https://www.nishithdesai.com/fileadmin/user_upload/pdfs/Research_Papers/Digital_Health_in_India.pdf https://www.nishithdesai.com/fileadmin/user_upload/pdfs/Research_Papers/Digital_Health_in_India.pdf</Citation></Reference><Reference><Citation>Ayushman Bharat digital mission 2024.  [
Jul;
2024 
]. 2024. https://abdm.gov.in/ https://abdm.gov.in/</Citation></Reference><Reference><Citation>Walia K, Pradhan R. Empowering healthcare: the vital role of digitizing the diagnostic labs in India’s healthcare ecosystem through ABDM.  [
Jul;
2024 
]. 2024. https://thepublichealthforum.com/2024/03/09/article-2/ https://thepublichealthforum.com/2024/03/09/article-2/</Citation></Reference><Reference><Citation>ABDM sandbox environment. ABDM Sandbox Environment.  [
Jul;
2024 
]. 2024. https://sandbox.abdm.gov.in/sandbox/v3/ https://sandbox.abdm.gov.in/sandbox/v3/</Citation></Reference><Reference><Citation>Barriers in access to oncology drugs - a global crisis. Barrios C, de Lima Lopes G, Yusof MM, Rubagumya F, Rutkowski P, Sengar M. Nat Rev Clin Oncol. 2023;20:7–15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9665041</ArticleId><ArticleId IdType="pubmed">36380066</ArticleId></ArticleIdList></Reference><Reference><Citation>Financial toxicity in cancer care in India: a systematic review. Boby JM, Rajappa S, Mathew A. Lancet Oncol. 2021;22:541–549.</Citation><ArticleIdList><ArticleId IdType="pubmed">34856151</ArticleId></ArticleIdList></Reference><Reference><Citation>Pricing of cancer medicines and its impacts.  [
Jul;
2024 
]. 2018. https://apps.who.int/iris/bitstream/handle/10665/277190/9789241515115-eng.pdf https://apps.who.int/iris/bitstream/handle/10665/277190/9789241515115-eng.pdf</Citation></Reference><Reference><Citation>Cancer medicines: what is essential and affordable in India? Sengar M, Fundytus A, Hopman W, et al. JCO Glob Oncol. 2022;8:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9812506</ArticleId><ArticleId IdType="pubmed">35853192</ArticleId></ArticleIdList></Reference><Reference><Citation>Recent updates on cancer immunotherapy. Liu M, Guo F. Precis Clin Med. 2018;1:65–74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6333045</ArticleId><ArticleId IdType="pubmed">30687562</ArticleId></ArticleIdList></Reference><Reference><Citation>Personalized immunotherapy in cancer precision medicine. Kiyotani K, Toyoshima Y, Nakamura Y. Cancer Biol Med. 2021;18:955–965.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8610159</ArticleId><ArticleId IdType="pubmed">34369137</ArticleId></ArticleIdList></Reference><Reference><Citation>Personalized oncology meets immunology: the path toward precision immunotherapy. Mandal R, Chan TA. Cancer Discov. 2016;6:703–713.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4930745</ArticleId><ArticleId IdType="pubmed">27107038</ArticleId></ArticleIdList></Reference><Reference><Citation>Genomics-guided immunotherapy for precision medicine in cancer. Mukherjee S. Cancer Biother Radiopharm. 2019;34:487–497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6802731</ArticleId><ArticleId IdType="pubmed">31314580</ArticleId></ArticleIdList></Reference><Reference><Citation>A real-world data of Immune checkpoint inhibitors in solid tumors from India. Noronha V, Abraham G, Patil V, et al. Cancer Med. 2021;10:1525–1534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7940210</ArticleId><ArticleId IdType="pubmed">33591635</ArticleId></ArticleIdList></Reference><Reference><Citation>Low-dose immunotherapy in head and neck cancer: a randomized study. Patil VM, Noronha V, Menon N, et al. J Clin Oncol. 2023;41:222–232.</Citation><ArticleIdList><ArticleId IdType="pubmed">36265101</ArticleId></ArticleIdList></Reference><Reference><Citation>Cost savings and increased access with ultra-low-dose immunotherapy. Mitchell AP, Goldstein DA. J Clin Oncol. 2023;41:170–172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839306</ArticleId><ArticleId IdType="pubmed">36265102</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayushman Bharat - national health protection mission.  [
Jun;
2024 
]. 2024. http://www.india.gov.in/spotlight/ayushman-bharat-national-health-protection-mission http://www.india.gov.in/spotlight/ayushman-bharat-national-health-protection-mission</Citation></Reference><Reference><Citation>Biosimilars - how can we realize the $240 billion opportunity.  [
Jul;
2024 
]. 2016. http://www.sathguru.com/news/2016/10/10/biosimilars-how-can-we-realize-the-240-bn-opportunity/ http://www.sathguru.com/news/2016/10/10/biosimilars-how-can-we-realize-the-240-bn-opportunity/</Citation></Reference><Reference><Citation>Challenge of incorporating new drugs for breast cancer in Brazil: a proposed framework for improving access to innovative therapies. Barrios C, Freitas-Junior R, Martins S, Bines J, Estevez-Diz MD, Caleffi M. JCO Glob Oncol. 2021;7:474–485.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8081546</ArticleId><ArticleId IdType="pubmed">33822641</ArticleId></ArticleIdList></Reference><Reference><Citation>Finishing the euchromatic sequence of the human genome. International Human Genome Sequencing Consortium. Nature. 2004;431:931–945.</Citation><ArticleIdList><ArticleId IdType="pubmed">15496913</ArticleId></ArticleIdList></Reference><Reference><Citation>All of Us research program overview.  [
Jul;
2024 
]. 2024. https://allofus.nih.gov/about/program-overview https://allofus.nih.gov/about/program-overview</Citation></Reference><Reference><Citation>What is UK Biobank?  [
Jul;
2024 
]. 2024. https://www.ukbiobank.ac.uk/ https://www.ukbiobank.ac.uk/</Citation></Reference><Reference><Citation>European '1+ million genomes' initiative.  [
Jul;
2024 
];https://digital-strategy.ec.europa.eu/en/policies/1-million-genomes 2024 1</Citation></Reference><Reference><Citation>Personalized care, healthier living.  [
Jul;
2024 
]. 2024. https://www.qphi.org.qa/ https://www.qphi.org.qa/</Citation></Reference><Reference><Citation>10 largest biobanks in the world.  [
Jul;
2024 
];https://www.biobanking.com/10-largest-biobanks-in-the-world/ World. 2021 10</Citation></Reference><Reference><Citation>The Qatar Biobank: background and methods. Al Kuwari H, Al Thani A, Al Marri A, et al. BMC Public Health. 2015;15:1208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4669623</ArticleId><ArticleId IdType="pubmed">26635005</ArticleId></ArticleIdList></Reference><Reference><Citation>A genome atlas mapping cancers in India. Dhup S, Ramamurthy R. Nat India. 2024:44151–44124.</Citation></Reference><Reference><Citation>What is GenomeIndia?  [
Jul;
2024 
]. 2024. https://genomeindia.in/ https://genomeindia.in/</Citation></Reference><Reference><Citation>IndiGen: genomics for public health in India.  [
Jul;
2024 
]. 2024. https://indigen.igib.in/ https://indigen.igib.in/</Citation></Reference><Reference><Citation>Indian cancer genome atlas.  [
Jul;
2024 
]. 2024. https://www.icga.in/ https://www.icga.in/</Citation></Reference><Reference><Citation>The precision medicine initiative 2016.  [
Jun;
2024 
]. 2024. https://obamawhitehouse.archives.gov/precision-medicine https://obamawhitehouse.archives.gov/precision-medicine</Citation></Reference><Reference><Citation>NCI NCI. Precision medicine.  [
Jul;
2024 
]. 2024. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/precision-medicine https://www.cancer.gov/publications/dictionaries/cancer-terms/def/precision-medicine</Citation></Reference><Reference><Citation>Precision medicine—personalized, problematic, and promising. Jameson JL, Longo DL. N Engl J Med. 2015;372:2229–2234.</Citation><ArticleIdList><ArticleId IdType="pubmed">26014593</ArticleId></ArticleIdList></Reference><Reference><Citation>Global research trends on precision oncology: a systematic review, bibliometrics, and visualized study. Zhang B, Ao B, Lu X, et al. Medicine (Baltimore) 2022;101:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9622693</ArticleId><ArticleId IdType="pubmed">36316889</ArticleId></ArticleIdList></Reference><Reference><Citation>The cancer genome. Stratton MR, Campbell PJ, Futreal PA. Nature. 2009;458:719–724.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2821689</ArticleId><ArticleId IdType="pubmed">19360079</ArticleId></ArticleIdList></Reference><Reference><Citation>Precision oncology: who, how, what, when, and when not? Schwartzberg L, Kim ES, Liu D, Schrag D. Am Soc Clin Oncol Educ Book. 2017;37:160–169.</Citation><ArticleIdList><ArticleId IdType="pubmed">28561651</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiogenomics: a key component of precision cancer medicine. Liu Z, Duan T, Zhang Y, et al. Br J Cancer. 2023;129:741–753.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10449908</ArticleId><ArticleId IdType="pubmed">37414827</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacogenomics: current status and future perspectives. Pirmohamed M. Nat Rev Genet. 2023;24:350–362.</Citation><ArticleIdList><ArticleId IdType="pubmed">36707729</ArticleId></ArticleIdList></Reference><Reference><Citation>Why do people still think data is the new oil?  [
Jul;
2024 
]. 2018. https://datainnovation.org/2018/01/why-do-people-still-think-data-is-the-new-oil/ https://datainnovation.org/2018/01/why-do-people-still-think-data-is-the-new-oil/</Citation></Reference><Reference><Citation>Axes of a revolution: challenges and promises of big data in healthcare. Shilo S, Rossman H, Segal E. Nat Med. 2020;26:29–38.</Citation><ArticleIdList><ArticleId IdType="pubmed">31932803</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature Research. Advancing precision medicine using AI and big data 2024.  [
Jul;
2024 
]. 2024. https://www.nature.com/articles/d42473-020-00349-9 https://www.nature.com/articles/d42473-020-00349-9</Citation></Reference><Reference><Citation>The Drugs and Cosmetics Act and Rules.  [
Aug;
2024 
]. 2016. https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf</Citation></Reference><Reference><Citation>GOVERNMENT OF INDIA. The Patents Act. THE PATENTS ACT.  [
Aug;
2024 
]. 1970. https://ipindia.gov.in/writereaddata/Portal/IPOAct/1_113_1_The_Patents_Act_1970_-_Updated_till_23_June_2017.pdf https://ipindia.gov.in/writereaddata/Portal/IPOAct/1_113_1_The_Patents_Act_1970_-_Updated_till_23_June_2017.pdf</Citation></Reference><Reference><Citation>Drugs and cosmetics (second amendment) rules.  [
Aug;
2024 
];GOVERNMENT OF INDIA. DRUGS AND COSMETICS (IIND. https://www.ibkp.dbtindia.gov.in/DBT_Content_Test/CMS/Guidelines/20181115121749531_Schedule_Y.pdf 2005 20181115121749531</Citation></Reference><Reference><Citation>GOVERNMENT OF INDIA. Good clinical practice guidelines.  [
Aug;
2024 
]. 2003. https://www.rgcb.res.in/documents/Good-Clinical-Practice-Guideline.pdf https://www.rgcb.res.in/documents/Good-Clinical-Practice-Guideline.pdf</Citation></Reference><Reference><Citation>GOVERNMENT OF INDIA. Clinical trial. Clinical Trial.  [
Aug;
2024 
]. 2018. https://www.cdsco.gov.in/opencms/opencms/en/Clinical-Trial/Global-Clinical-Trial/ https://www.cdsco.gov.in/opencms/opencms/en/Clinical-Trial/Global-Clinical-Trial/</Citation></Reference><Reference><Citation>Indian Council of Medical Research. Indian Council. for Medical Research Guidelines for Biomedical and Health Research Involving Human Participants; [ Jul; 2024 ]. 2017. National ethical guidelines for biomedical and health research involving human participants.</Citation></Reference><Reference><Citation>GOVERNMENT OF INDIA. The new drugs and clinical trials rules, 2019.  [
Aug;
2024 
]. 2019. https://www.cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=OTg4OA== https://www.cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=OTg4OA==</Citation></Reference><Reference><Citation>GOVERNMENT OF INDIA. The amendments to the new drugs and clinical trials rules.  [
Jul;
2024 
]. 2022. https://www.cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=OTg4OA== https://www.cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=OTg4OA==</Citation></Reference><Reference><Citation>PWC India. Clinical trial opportunities in India.  [
Aug;
2024 
]. 2023. https://www.pwc.in/assets/pdfs/consulting/management-consulting/clinical-trial-opportunities-in-india.pdf https://www.pwc.in/assets/pdfs/consulting/management-consulting/clinical-trial-opportunities-in-india.pdf</Citation></Reference><Reference><Citation>Clinical trial network. Clinical trial network.  [
Aug;
2024 
]. 2023. https://birac.nic.in/nbm/cms/page/clinical-trial-network https://birac.nic.in/nbm/cms/page/clinical-trial-network</Citation></Reference><Reference><Citation>About National Cancer Grid. About National Cancer Grid (NCG.  [
Jul;
2024 
]. 2024. https://www.ncgindia.org/about https://www.ncgindia.org/about</Citation></Reference><Reference><Citation>The national cancer grid of India. Pramesh CS, Badwe RA, Sinha RK. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202620/ Indian J Med Paediatr Oncol. 2014;35:226–227.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4202620</ArticleId><ArticleId IdType="pubmed">25336795</ArticleId></ArticleIdList></Reference><Reference><Citation>Translational research: crossing the valley of death. Butler D. Nature. 2008;453:840–842.</Citation><ArticleIdList><ArticleId IdType="pubmed">18548043</ArticleId></ArticleIdList></Reference><Reference><Citation>The next generation of evidence-based medicine. Subbiah V. Nat Med. 2023;29:49–58.</Citation><ArticleIdList><ArticleId IdType="pubmed">36646803</ArticleId></ArticleIdList></Reference><Reference><Citation>Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols. Park JJ, Siden E, Zoratti MJ, et al. Trials. 2019;20:572.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6751792</ArticleId><ArticleId IdType="pubmed">31533793</ArticleId></ArticleIdList></Reference><Reference><Citation>The Master Observational Trial: a new class of master protocol to advance precision medicine. Dickson D, Johnson J, Bergan R, Owens R, Subbiah V, Kurzrock R. Cell. 2020;180:9–14.</Citation><ArticleIdList><ArticleId IdType="pubmed">31951522</ArticleId></ArticleIdList></Reference><Reference><Citation>Re-inventing drug development: a case study of the I-SPY 2 breast cancer clinical trials program. Das S, Lo AW. Contemp Clin Trials. 2017;62:168–174.</Citation><ArticleIdList><ArticleId IdType="pubmed">28899813</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol. Redman MW, Papadimitrakopoulou VA, Minichiello K, et al. Lancet Oncol. 2020;21:1589–1601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8109255</ArticleId><ArticleId IdType="pubmed">33125909</ArticleId></ArticleIdList></Reference><Reference><Citation>Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension. Liu X, Cruz Rivera S, Moher D, Calvert MJ, Denniston AK. Nat Med. 2020;26:1364–1374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598943</ArticleId><ArticleId IdType="pubmed">32908283</ArticleId></ArticleIdList></Reference><Reference><Citation>Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI Extension. Rivera SC, Liu X, Chan AW, Denniston AK, Calvert MJ. BMJ. 2020;370</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7490785</ArticleId><ArticleId IdType="pubmed">32907797</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>